Early Access

Back to JNJ

JOHNSON & JOHNSON EPS (Diluted) 2007-2025 | JNJ

Beta

What is eps (diluted)?

Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.

What is JOHNSON & JOHNSON's current eps (diluted)?

JOHNSON & JOHNSON (JNJ) annual eps (diluted) for 2025 was $11.03, a 90.50% increase from 2024. JOHNSON & JOHNSON eps (diluted) for the quarter ending September 28, 2025 was $2.12.

What was JOHNSON & JOHNSON's eps (diluted) in 2024?

JOHNSON & JOHNSON annual eps (diluted) for 2024 was $5.79, a 57.80% decline from 2023.

What was JOHNSON & JOHNSON's eps (diluted) in 2023?

JOHNSON & JOHNSON annual eps (diluted) for 2023 was $13.72, a 75.67% increase from 2022.

What is JOHNSON & JOHNSON's 4-year eps (diluted) CAGR?

JOHNSON & JOHNSON eps (diluted) grew at a compound annual growth rate (CAGR) of 18.95% from FY2021 to FY2025, going from $5.51 to $11.03 over 4 years.

EPS (Diluted) History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+14.4%
FY2019
$5.63
FY2025
$11.03
07081011121314161718192122232425
5 years selected
EPS (Diluted) History
PeriodValueChangeSource
FY2025$11.03+90.5%10-K
FY2024$5.79-57.8%10-K
FY2023$13.72+75.7%10-K
FY2022$7.81+41.7%10-K
FY2021$5.51-2.1%10-K
FY2019$5.63+0.4%10-K
FY2018$5.61+1093.6%10-K
FY2017$0.47-91.4%10-K
FY2016$5.48-3.9%10-K
FY2014$5.70+18.5%10-K
FY2013$4.81+24.6%10-K
FY2012$3.86-19.2%10-K
FY2011$4.78+8.6%10-K
FY2010$4.40-3.7%10-K
FY2008$4.57+25.9%10-K
FY2007$3.63-10-K
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →